Clinical Trials Logo

Myocardial Ischemia clinical trials

View clinical trials related to Myocardial Ischemia.

Filter by:

NCT ID: NCT05099692 Recruiting - Clinical trials for Coronary Heart Disease

CHD Patient's Concern on Cardiac Rehabilitation

Start date: October 15, 2021
Phase:
Study type: Observational

Our study focuses on the question about primary cardiac rehabilitation (CR) patients with coronary heart disease are concerned about demonstrating the association between the patients' view of CR and social associated factors. In our study, all participants are invited to choose at least 1 question in 15 questions or provide their questions regarding their doubt about the CR after filling in their personal information. The selectable questions can be categorized into five titles: the content or purpose of CR, the method of CR, the advantage of CR, the adverse effect of CR, and the expenditure of CR.

NCT ID: NCT05094843 Recruiting - Lung Cancer Clinical Trials

The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery

Start date: February 1, 2022
Phase:
Study type: Observational [Patient Registry]

Lung cancer surgery causes significant changes in the small circulation as well as changes in the intrathoracic anatomy. The effects of lung cancer surgery on electrocardiography and the cardiac stress associated with the procedures have not been previously extensively studied. The aim of the present study is to ascertain whether modern mini-invasive lung cancer surgery causes changes in the electrocardiogram, and whether these changes are transitory during short-term follow-up. Furthermore, the study aims to describe whether lung cancer surgery causes significant cardiac stress detectable by intraoperative electrocardiography.

NCT ID: NCT05092711 Recruiting - Clinical trials for Ischemic Heart Disease

Cardiovascular Risk Factors , Complications and Threputic Management Strategies in Patients With Coronary Heart Disease and COVID 19

Start date: July 1, 2022
Phase:
Study type: Observational

Using INTERASPIRE model to determine patients with established CHD whether the guidelines on cardiovascular disease prevention are being followed or not with incorporation of COVID 19 as a risk factor with the other classical risk factors to understand significance of the new pandemic virus in mortality and morbidity of CVD and coronary events in association with the other known classical risk factors .

NCT ID: NCT05091749 Recruiting - Clinical trials for Chronic Coronary Syndromes

Detection of Significant Coronary Artery Disease by Promising Biomarker: A2A Adenosine Receptor (A2AR) Assays

ADOCAD
Start date: November 9, 2021
Phase: N/A
Study type: Interventional

Transversal, national, multi-center study with progressive recruitment designed to assess the diagnostic accuracy of A2AR expression for the identification of significant obstructive CAD (FFR<0.8) of patients suspected of CCS compared to the gold standard. 1. To assess the diagnostic accuracy of the A2AR profile (i.e. KD/EC50) for identifying myocardial ischemia in patients with suspected CCS compared to the gold standard inducible myocardial ischemia. 2. To determine the best threshold value for A2AR expression for identifying significant obstructive CAD (FFR<0,8) in patients with CCS, and to estimate the diagnostic performances associated with the identified threshold 3. To determine the best threshold value for A2AR profile (i.e. KD/EC50) for identifying myocardial ischemia (See annex 2) in patients with CCS and to estimate the diagnostic performances associated with the identified threshold.

NCT ID: NCT05081999 Recruiting - Clinical trials for Coronary Artery Disease

De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease

ABBREVIATE
Start date: January 30, 2023
Phase: Phase 4
Study type: Interventional

Patients with heart disease are often prescribed many medications and these patients may experience drug interactions or negative drug related side effects. With newer medications and treatments available, it is not well known whether older drugs, such as beta-blockers, are still an effective and safe option for treating heart disease. Some evidence suggests beta-blockers should be continued, whereas other evidence suggests beta-blockers might cause unnecessary harm. The study hopes to determine whether continuation or discontinuation of beta-blockers will affect long term cardiovascular outcomes. The study investigators will also examine how beta-blockers continuation or discontinuation affects several quality of life measures.

NCT ID: NCT05079958 Recruiting - Clinical trials for Coronary Artery Disease

Effects of Cognitive-behavioral Education and Exercise Interventions on Smoking Cessation

Start date: October 30, 2019
Phase: N/A
Study type: Interventional

The purpose of the study is to adopt the Trans-theoretical Model to facilitate step-by-step changes in a patient's smoking behavior and explore the effect of "Cognitive-Behavioral Education Course" and "Exercise Program" on Smoking cessation, physical health, and mental health of smokers with CAD.

NCT ID: NCT05075317 Recruiting - Clinical trials for Coronary Artery Disease

Time Restricted Eating and Cardiac Rehabilitation

TREat-CR
Start date: July 11, 2022
Phase: N/A
Study type: Interventional

This study will use a form of intermittent fasting called time-restricted eating (TRE) where individuals consume ad libitum energy intake within a set window of time, commonly 8 hours, which induces a fasting window of 16 hours per day (i.e., 16:8 TRE). TRE could be an effective addition to cardiac rehabilitation as it has demonstrated cardiovascular health benefits and potential for synergy when combined with exercise training. This study will determine if TRE is a feasible and safe nutrition intervention during cardiac rehabilitation and if TRE improves the health benefits of cardiac rehabilitation compared to cardiac rehabilitation alone.

NCT ID: NCT05056662 Recruiting - Coronary Disease Clinical Trials

Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions

PROPHET-FFR
Start date: June 4, 2020
Phase:
Study type: Observational [Patient Registry]

PROPHET-FFR is a single center ambispective registry aiming to explore the impact of post-revascularization functional assessment on later outcomes.

NCT ID: NCT05045118 Recruiting - Clinical trials for Ischaemic Heart Disease

The Impact of Structured Patient Education Material (SPEM) in Improving Clinical and Behavioural Outcomes in Home-based Cardiac Rehabilitation Program Participants: A Pilot Study

Start date: March 30, 2021
Phase: N/A
Study type: Interventional

This study aims to examine the impact of providing a digital education material to participants of home based cardiac rehabilitation in improving clinical and behavioural outcomes

NCT ID: NCT05044273 Recruiting - Clinical trials for Coronary Artery Disease

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

IRIS SynergyXD
Start date: September 1, 2022
Phase:
Study type: Observational [Patient Registry]

The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.